Please login to the form below

Not currently logged in
Email:
Password:

gastroenterology

This page shows the latest gastroenterology news and features for those working in and with pharma, biotech and healthcare.

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Dr Asit Parikh, head of gastroenterology therapeutic area unit at Takeda, said: “Today’s marketing authorisation, the first for an allogeneic stem cell therapy, represents a positive advancement in the treatment

Latest news

More from news
Approximately 2 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Imperial College London is ranked as the number one UK university in the respiratory, cardiovascular and gastroenterology fields, so it is sad and startling to discover such a huge disconnect between

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    In 2015, low demand specialties included areas such as pathology and radiology, while examples of middling demand specialties were gastroenterology and nephrology; high-demand specialties included family medicine and adult psychiatry.

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    These deals were mainly early stage deals in the areas of gastroenterology, neurodegenerative diseases and an $830m ($40m upfront) deal with Mersana for rights outside North America to a phase 1

  • Opening up innovation Opening up innovation

    The second will probably be gastroenterology. The third might be nephrology, depending on the data.”.

  • Deal Watch July 2016 Deal Watch July 2016

    Recordati has been busy on the acquisition front recently; in May the company acquired Italichimici for $145m, strengthening its gastroenterology and respiratory ranges, and in July it bought the Swiss company

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

  • emotive bolsters client services team emotive bolsters client services team

    During her six years at Chameleon, she was responsible for medical communications acitivites in various therapy areas including diabetes, cardiology, immunology, gastroenterology and rare diseases.

  • Clark Health Communications expands team Clark Health Communications expands team

    responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business. ... Campbell will support and assist the team across its women’s health, gastroenterology and haemophilia accounts.

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

  • Virgo Health Education expands team Virgo Health Education expands team

    Prior to this, he served as a medial doctor at Chelsea &Westminster hospital, working in a number of specialties including acute medicine, gastroenterology and colorectal surgery.

  • Dr Andrew Mulberg moves from FDA to Amicus Therapeutics Dr Andrew Mulberg moves from FDA to Amicus Therapeutics

    He joins Amicus from the US Food and Drug Administration ( FDA), where he most recently served as deputy director of the division of gastroenterology and inborn errors products. ... Dr Mulberg is a pediatric gastroenterologist, and was attending

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics